mercredi 4 octobre 2017

Onco Actu du 4 octobre 2017

1. Biologie

Overactive gene associated with more aggressive forms of bone marrow cancer myeloma [Institute of Cancer Research]

2.7 Etiologie - Obésité

Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity — United States, 2005–2014 [CDC]

Behind the numbers: cancers associated with obesity [ACS]

Cancers linked to excess weight make up 40% of all US diagnoses, study finds [The Guardian]

Obesity-related cancers rising, threatening gains in U.S. cancer rates [Reuters]

4. Dépistage, diagnostic et pronostic

3D microscopy gives more accurate cancer diagnosis [Karolinska Institutet]

4.2 Dép., diag. & prono. - Génome

Personal Genetic Testing Is Here. Do We Need It? [NY Times]

5.12 Immunothérapies

Cancer-fighting power couple tackles mysteries of the immune system [Washington Post]

5.12.1 Immunothérapies - partenariats

Amgen helps Immatics to $58M round to fund cancer trials [FierceBiotech]

Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer [EndPoints]

5.12.2 Immunothérapies - CAR-T

Dear Kite: With 2300% upside, we blazed an amazing trail [EndPoints]

5.12.3 Immunothérapies-combinaisons

Timing and Sequence Critical for Immunotherapy Combination [NCI]

5.2.1 Pharma - Partenariats

Amgen comes up with $1.5B package to partner with CytomX on a preclinical Probody approach to cancer [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Patients often demand experimental drugs that prove ineffective — report [EndPoints]

6.1 Observation

Breast Cancer Statistics, 2017 [ACS]

6.11 Patients

Julia Louis-Dreyfus Raises Discussion-Worthy Points In Her Breast Cancer Update [Forbes]

6.3 Associations/Fondations

Cancer Research UK's Chief Executive to stand down in spring 2018 [Cancer Research UK]

6.7 DMP, Big Data & applis

Knock Six Years Off Your Timeline. Um. [In the Pipeline]